Rod Dunbar
Rod Dunbar is currently Director of the Maurice Wilkins Centre, one of New Zealand's seven Centres of Research Excellence. His laboratory at The University of Auckland's School of Biological Sciences focuses on human cellular immunity, with a particular interest in developing new immunotherapies for melanoma. in collaboration with Prof Margaret Brimble's medicinal chemistry group, he recently established a GMP laboratory that is now licensed to manufacture synthetic long peptides for use in cancer immunotherapy trials. Rod gained his MBChB and PhD from the University of Otago, then spent 6 years as a post-doc at the University of Oxford, where he was involved in many of the first studies of human T cell responses using MHC class I "tetramers". His return to New Zealand in 2002 was enabled by the award of a Wellcome Trust International Senior Research Fellowship.
Abstracts this author is presenting:
